Navigation Links
ARX-01 and ARX-03 Clinical Results Presented at the 30th Annual Scientific Meeting of the American Pain Society
Date:5/18/2011

ess and advantages of its post-operative pain management approach and product candidate development.  These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties.  AcelRx Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: the success, cost and timing of AcelRx Pharmaceutical's product development activities and clinical trials; its ability to obtain and maintain regulatory approval of its product candidates; its ability to obtain funding for its operations; its plans to research, develop and commercialize its product candidates; its ability to attract collaborators with development, regulatory and commercialization expertise; the accuracy of AcelRx Pharmaceutical's estimates regarding expenses, capital requirements and needs for financing; and other risks detailed in the "Risk Factors" and elsewhere in AcelRx Pharmaceuticals' Securities and Exchange Commission filings and reports, including its Annual Report on Form 10-K for the year ended December 31, 2010 and its Quarterly Report on From 10-Q for the three months ended March 31, 2011.  AcelRx Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.


'/>"/>
SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
2. AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
3. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 3, 2015 ... del 100% de participación en ZAO "Biocom" en ... marca la incursión de Lupin en el mercado ... RUB en ventas, colocándolo como uno de los ... (IMS Health). Durante más de una década, el ...
(Date:7/2/2015)... HOUSTON, TX and VANCOUVER , ... the "Company") (TSX-V: EPI) announced today that its common shares ... Capital Market ("NASDAQ") under the symbol "EPIX". ESSA ... Company will retain its listing on the TSX Venture Exchange ... the listing of the common shares on the NASDAQ, each ...
(Date:7/2/2015)... Fla. , July 2, 2015  Fort ... is pleased to announce that its Consumer Group ... Beverages") to Kerry Group plc (ISE: KRZ) ("Kerry"), ... taste and nutrition systems, as well as functional ... and pharmaceutical markets. Farlie Turner served as the ...
Breaking Medicine Technology:Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2
... a privately held company that has developed an all new ... it has reached an agreement with The Tech Group ... , to be the premier manufacturer of the Trio™ ... contract also includes development and engineering services from Insight Product ...
... Jan. 6, 2012 Breckenridge Pharmaceutical, Inc.announced that it ... different Abbreviated New Drug Applications (ANDA) during the 2011 ... (5) each year for the next several years.  These ... IV opportunities -- both blockbuster and niche products -- ...
Cached Medicine Technology:Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™" 2Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™" 3
(Date:7/3/2015)... Lenexa, KS (PRWEB) , ... July 03, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... Okla. One of the top-ranked executive search firms in the healthcare industry, B. ...
(Date:7/3/2015)... Orange, CT (PRWEB) , ... July 03, 2015 , ... ... at home is a good blender and easily accessible, quality ingredients. Aurora Natural is ... your smoothie for an added boost of fiber, protein, antioxidants, vitamins and minerals! , ...
(Date:7/3/2015)... ... , ... Jennifer Renee Hanes, DO is the new Medical Director of its ... independent freestanding emergency rooms in the United States. , “We are excited to welcome ... Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. , ...
(Date:7/3/2015)... ... ... Selfie on a Stick ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... smartphone has an incredibly powerful camera built into it. And when someone is traveling ...
(Date:7/3/2015)... ... ... Every year, One-to-1 Fitness and the Red Deer Fit Body ... community with free fitness training and indoor fitness boot camp classes for 24 straight ... thousands of charity dollars and ended with a $10,000 donation to the Jumpstart organization. ...
Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
... 28 MSA (NYSE: MSA ) today announced that net ... $293.2 million for the second quarter of 2008, a decrease of $66.0 ... 2009 was $12.5 million, or 35 cents per basic share, a decrease ... cents per basic share, for the same quarter last year. , ...
... , EAST RUTHERFORD, N.J., July 28 Cambrex Corporation (NYSE: CBM ) announced ... closes. , , The Company will host a conference call to discuss the ... Second Quarter 2009 Earnings Conference Call, ... 5, 2009 at 8:30 a.m. Eastern Time, Dial-in: ...
... experts say , TUESDAY, July 28 (HealthDay News) -- Antiviral ... elderly and should be reserved for young people, suggest researchers ... on the spread of the H1N1 virus. , If the ... drugs would not significantly reduce death rates among people older ...
... , DES PLAINES, Ill., July 28 Our ... for thousands of nurses, emergency departments are the sources of injury. ... that more than half of emergency nurses report experiencing physical violence ... shoved," "scratched," and "kicked." One in four has experienced such ...
... , , ... 28 CVS Caremark (NYSE: CVS ) announced today ... President/Chief Operating Officer of MinuteClinic, the company,s retail-based health clinic subsidiary, ... In his new roles, Dr. Sussman will be responsible for ...
... 28 On a routine day, Specialty Silicone Fabricators in ... drains, catheter systems, intravenous drug delivery devices and pacemaker leads. ... of these miniature products. Considering that silicone is a highly ... is no small achievement. , , ...
Cached Medicine News:Health News:MSA Announces Second Quarter Results 2Health News:MSA Announces Second Quarter Results 3Health News:MSA Announces Second Quarter Results 4Health News:MSA Announces Second Quarter Results 5Health News:MSA Announces Second Quarter Results 6Health News:MSA Announces Second Quarter Results 7Health News:MSA Announces Second Quarter Results 8Health News:Save Swine Flu Drugs for Younger Patients, Study Urges 2Health News:More Than Half of Emergency Department Nurses Have Been Physically Assaulted at Work, New Study Finds 2Health News:More Than Half of Emergency Department Nurses Have Been Physically Assaulted at Work, New Study Finds 3Health News:CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic 2Health News:CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic 3Health News:When You Make Things That Get Implanted in People, Small Things Count 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: